State of Wyoming Invests $751,000 in Centene Corporation $CNC

State of Wyoming bought a new stake in shares of Centene Corporation (NYSE:CNC) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 11,695 shares of the company’s stock, valued at approximately $751,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CNC. Baird Financial Group Inc. acquired a new position in shares of Centene in the 1st quarter worth approximately $236,000. Sivia Capital Partners LLC lifted its stake in Centene by 80.0% during the second quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock valued at $527,000 after purchasing an additional 4,315 shares during the last quarter. CW Advisors LLC boosted its holdings in Centene by 20.3% during the second quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock worth $264,000 after buying an additional 820 shares in the last quarter. NewEdge Advisors LLC grew its position in Centene by 6.1% in the second quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after buying an additional 2,582 shares during the last quarter. Finally, Treasurer of the State of North Carolina increased its holdings in shares of Centene by 0.4% in the second quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock valued at $12,590,000 after buying an additional 967 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors.

Centene Trading Up 0.1%

NYSE CNC opened at $67.53 on Monday. The company has a market capitalization of $33.36 billion, a PE ratio of -6.47, a price-to-earnings-growth ratio of 0.36 and a beta of 1.08. Centene Corporation has a 1-year low of $27.76 and a 1-year high of $69.36. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.71. The firm’s fifty day simple moving average is $65.00 and its 200-day simple moving average is $51.69.

Centene (NYSE:CNC) last issued its earnings results on Tuesday, July 28th. The company reported $2.51 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $1.42. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The firm had revenue of $53.58 billion for the quarter, compared to the consensus estimate of $47.64 billion. During the same quarter in the previous year, the company posted ($0.16) earnings per share. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 4.800- EPS. As a group, sell-side analysts anticipate that Centene Corporation will post 4.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Morgan Stanley set a $66.00 price objective on Centene in a research note on Wednesday, July 29th. TD Cowen reaffirmed a “hold” rating and set a $65.00 target price (up from $47.00) on shares of Centene in a report on Tuesday, July 14th. Jefferies Financial Group increased their price target on Centene from $39.00 to $48.00 and gave the company a “hold” rating in a research report on Wednesday, April 29th. Barclays reissued an “overweight” rating and issued a $80.00 price target (up from $75.00) on shares of Centene in a research note on Wednesday, July 29th. Finally, Mizuho set a $63.00 price objective on shares of Centene and gave the company a “neutral” rating in a research note on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $69.15.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.